Words of warning – never try a new drug – unless there is no other option – until it has been on the market for at least 5 years. The HPV vaccine Gardasil was fast-tracked through the FDA – and the CDC makes a monetary gain on all vaccines sold. I am including another video of yet ‘one more girl’ adversely injured by Gardasil below.
There are so many flaws in the HPV vaccine – that I have posted about on this blog – and that are swirling around the Internet. What sense does it make to inoculate a young girl against 4 strains of the HPV virus (out of 100 or more) when cervical cancer which is preventable through adequate nutrition may not even occur until a woman is in her 50’s or 60’s. Remember the vaccine’s efficacy only last for 5 to 6 years.
And cervical cancer can be parlayed with the right nutritional support. Naturopathic physician, Dr. Marianne Marchese wrote about this in one of her many articles on her site. This article is titled: Cervical dysplasia and HPV.
But the time these young girls reach their 50’s and 60’s plasma thermograms could be part of annual screening tests.
HPV – Help Pay for Viox. Merck’s last but not latest foible.
‘Heat maps’ find cervical cancer
January 8, 2014
The “plasma thermogram” examines the proteins inside blood, including those produced by tumours.
A study, in the journal Plos One, showed the test could detect cervical cancer and how advanced it was.
Cancer Research UK said thermograms might improve detection, but more evidence on the accuracy and reliability was needed.
Screening for cervical cancer currently involves a looking for abnormal cells in a smear test and detecting high-risk viruses that can cause the disease.
The study, at the University of Louisville, used the plasma thermogram technology to analyse blood samples.
The sample will respond differently to heat depending on the types of proteins contained in the blood. It results in a thermogram – like a fingerprint – of the protein content.
The system was tested on 67 women with different stages of the cervical cancer to see if it could detect the differences between the patients and healthy people.
Lead researcher Dr Nichola Garbett said: “We have been able to demonstrate a more convenient, less intrusive test for detecting and staging cervical cancer.”
She said the test could be used to determine which cancers needed to be treated and which needed monitoring.
HPV, FDA, CDC and Merck Controversy